SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-18-008190
Filing Date
2018-07-02
Accepted
2018-07-02 21:46:18
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp93048_4.html 4  
1 FORM 4 dp93048_4.xml 4 4676
  Complete submission text file 0000950103-18-008190.txt   7197
Mailing Address BLOCK 2, MIESIAN PLAZA 50-58 BAGGOT STREET LOWER DUBLIN 2 L2 D02 HW68
Business Address BLOCK 2, MIESIAN PLAZA 50-58 BAGGOT STREET LOWER DUBLIN 2 L2 D02 HW68 353-1-609-6000
Shire plc (Reporting) CIK: 0000936402 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38550 | Film No.: 18934615
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Issuer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 SHIRE WAY LEXINGTON MA 02421
Business Address 300 SHIRE WAY LEXINGTON MA 02421 (617) 588-8119
Shire Human Genetic Therapies, Inc. (Reporting) CIK: 0001745009 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38550 | Film No.: 18934614